However, in human liver samples from obese subjects with and without nonalcoholic fatty liver disease (NAFLD), those with NAFLD exhibited lower serum concentrations of prolactin (5). This evidence concerns the gene PRL and metabolic dysfunction-associated steatotic liver disease.